Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$40,878,917
+$2,349,791 QoQ
Shares Held
162,450
-3.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.74%
of 13F equity value
Holder Rank
#414
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. ABBV ranks #2 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,878,917 | 162,450 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $38,529,126 | 168,625 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $40,409,286 | 174,524 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $30,083,061 | 162,068 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $34,109,017 | 162,796 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $30,134,898 | 169,583 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $34,063,325 | 172,490 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $29,375,887 | 171,268 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $29,825,248 | 163,785 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $21,674,104 | 139,860 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $23,725,283 | 159,166 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $21,219,300 | 157,495 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $25,503,502 | 160,027 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $26,009,836 | 160,942 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $22,041,978 | 164,235 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $25,337,258 | 165,430 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $27,345,038 | 168,682 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $23,253,866 | 171,742 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $18,617,606 | 172,593 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $19,171,553 | 170,202 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $18,103,581 | 167,285 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $17,907,979 | 167,130 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $14,270,862 | 162,928 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $16,006,088 | 163,028 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $15,144,818 | 198,777 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||